Company Overview

Padza company was established in 2017 with the aim of providing suitable diagnostic and therapeutic tools for biological research especially cancer. The company has so far produced tens of monoclonal antibodies related to cancer cell markers as well as hundreds monoclonal and polyclonal antibodies and their enzymatic conjugates and fluorescences.


Antibodies, highly specific and accurate tools for diagnosis and therapy